| Stage | HLNE | % of rev | UFPI | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $275M | 100.00% | $1.9B | 100.00% | UFPI ×6.84 |
| Gross profit | $168M | 60.90% | $290M | 15.41% | HLNE +45.5pp |
| Operating income | $126M | 45.93% | $103M | 5.49% | HLNE +40.4pp |
| Pre-tax income | $150M | 54.47% | $113M | 5.99% | HLNE +48.5pp |
| Net income | $125M | 45.36% | $83M | 4.42% | HLNE +40.9pp |
| Stage | HLNE | UFPI | Gap · A − B |
|---|---|---|---|
| Revenue | $275M100.00% | $1.9B100.00% | UFPI ×6.84 |
| Gross profit | 60.90%$168M | 15.41%$290M | HLNE +45.5pp |
| Operating income | 45.93%$126M | 5.49%$103M | HLNE +40.4pp |
| Pre-tax income | 54.47%$150M | 5.99%$113M | HLNE +48.5pp |
| Net income |
| 45.36%$125M |
| 4.42%$83M |
| HLNE +40.9pp |
No shared counterparties.